To view this email as a web page, click here.

 
FDA Rheumatology Drug Approvals: Pediatric lupus, spondyloarthritis and more
From a new biosimilar to a first-ever approved drug to treat pediatric lupus patients, the Food & Drug Administration has approved several new medications in recent months. In this slideshow, we offer a brief overview of these new therapeutics.
Read more
 
Exercise Lowers Risk of Rheumatoid Arthritis
Getting more exercise can reduce a woman’s risk of developing rheumatoid arthritis, according to new research.
Read more
 
MORE FROM RHEUMATOLOGY NETWORK
 
Contribute to Rheumatology Network
PsA Quiz: Can you identify the appropriate treatment for newly diagnosed patients?
Treatment Guidelines for Glucocorticoid Use

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.